Biologic targeting in the treatment of inflammatory bowel diseases

QR Code

Biologic targeting in the treatment of inflammatory bowel diseases

Matteo Bosani, Sandro Ardizzone, Gabriele Bianchi PorroChair of Gastroenterology, &ldquo;L. Sacco&rdquo; University Hospital, Milan, ItalyAbstract: The etiology of inflammatory bowel disease (IBD) has not yet been clarified and immunosuppressive agents which nonspecifically reduce in...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Matteo Bosani, Sandro Ardizzone, Gabriele Bianchi Porro
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2009
Sujets:	Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/d1dca0382bc1443b92e11b56a2f07343
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
par: Bosani M, et autres
Publié: (2014)

Adalimumab for the treatment of Crohn&rsquo;s disease
par: Andrea Cassinotti, et autres
Publié: (2008)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
par: Marafini I, et autres
Publié: (2020)

Editorial: Game Changers in Inflammatory Bowel Diseases
par: Anita Bálint, et autres
Publié: (2021)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
par: Al Sulais E, et autres
Publié: (2020)

Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with infection and co-existing inflammatory bowel disease
par: Hussam Murad, et autres
Publié: (2021)

RNA interference-based nanosystems for inflammatory bowel disease therapy
par: Guo J, et autres
Publié: (2016)

Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
par: Manil Kukar, et autres
Publié: (2009)

Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats
par: Lozano-Pérez AA, et autres
Publié: (2014)

The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
par: Jin-Woo Kim, et autres
Publié: (2021)

Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease
par: Truffi M, et autres
Publié: (2020)

Inflammatory bowel disease: clinical aspects and treatments
par: Fakhoury M, et autres
Publié: (2014)

Attributes of intestinal microbiota composition and their correlation with clinical primary nonresponse to anti-TNF-α agents in inflammatory bowel disease patients
par: Hanan Alatawi, et autres
Publié: (2021)

Factors associated with adherence to treatment in Iranian patients with inflammatory bowel disease
par: Zohre Forouzan, et autres
Publié: (2021)

Inflammatory Bowel Disease Monitor

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
par: Byron P. Vaughn
Publié: (2021)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
par: Debora Curci, et autres
Publié: (2021)

MSC therapy for inflammatory bowel disease
par: Mikhail A. Konoplyannikov, et autres
Publié: (2021)

Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases
par: Mercedes Lopez-Santalla, et autres
Publié: (2021)

The Prevalence of Adherent-Invasive Escherichia coli and Its Association With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
par: Razie Kamali Dolatabadi, et autres
Publié: (2021)

The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population
par: Zeng RZ, et autres
Publié: (2021)

Immunomodulatory role of Parkinson’s disease 7 in inflammatory bowel disease
par: Rita Lippai, et autres
Publié: (2021)

Biologic monotherapy in the treatment of rheumatoid arthritis
par: Detert J, et autres
Publié: (2015)

Biological drugs targeting the immune response in the therapy of psoriasis
par: Saveria Pastore, et autres
Publié: (2008)

Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
par: Lidiya V. Boldyreva, et autres
Publié: (2021)

Metalloproteinases in Inflammatory Bowel Diseases
par: Marônek M, et autres
Publié: (2021)

Seminars in inflammatory bowel disease
Publié: (2001)

Biologics: Targets & Therapy
Publié: (2009)

Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease
par: Lingling Qv, et autres
Publié: (2021)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
par: Rawla P, et autres
Publié: (2018)

Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment
par: Alaarg A, et autres
Publié: (2016)

Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management
par: Igor G. Bakulin, et autres
Publié: (2021)

Serum adropin levels are reduced in patients with inflammatory bowel diseases
par: Darko Brnić, et autres
Publié: (2020)

Serum biomarkers confirming stable remission in inflammatory bowel disease
par: Christoph Kessel, et autres
Publié: (2021)

Significance of serum palmitoleic acid levels in inflammatory bowel disease
par: Yuko Akazawa, et autres
Publié: (2021)

Classification of Paediatric Inflammatory Bowel Disease using Machine Learning
par: E. Mossotto, et autres
Publié: (2017)

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
par: Mohamed Mahdi-Rogers, et autres
Publié: (2010)

Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease
par: Yutaro Masu, et autres
Publié: (2021)

Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies
par: Elnaggar YSR, et autres
Publié: (2015)

The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer
par: Patrycja Kłos, et autres
Publié: (2021)